Microsatellite instability, prognosis and drug sensitivity of stage II and III colorectal cancer: more complexity to the puzzle
Contributors
Tejpar, Sabine; Saridaki, Zacharenia; Delorenzi, Mauro; Bosman, Fred; Roth, ArnaudPublished in
Journal of the National Cancer Institute, vol. 103, no. 11, p. 841-844Publication date
2011Keywords
- Antimetabolites, Antineoplastic/administration & dosage/adverse effects/therapeutic use
- Chemotherapy, Adjuvant
- Colorectal Neoplasms/drug therapy/genetics/pathology
- Colorectal Neoplasms, Hereditary Nonpolyposis/genetics
- CpG Islands/genetics
- DNA Methylation
- DNA Mismatch Repair/genetics
- Disease-Free Survival
- Fluorouracil/administration & dosage/adverse effects/therapeutic use
- Gene Silencing
- Germ-Line Mutation
- Humans
- Microsatellite Instability
- Neoplasm Staging
- Predictive Value of Tests
- Prognosis
- Randomized Controlled Trials as Topic
- Treatment Failure
UNIGE affiliation entities
UNIGE research groups
Citation (ISO format)
TEJPAR, Sabine et al. Microsatellite instability, prognosis and drug sensitivity of stage II and III colorectal cancer: more complexity to the puzzle. In: Journal of the National Cancer Institute, 2011, vol. 103, n° 11, p. 841–844. doi: 10.1093/jnci/djr170
Main files (1)
Article (Published version)
Identifiers
- PID : unige:24965
- DOI : 10.1093/jnci/djr170
- PMID : 21597023
